Dose response biology: The case of resveratrol

Human and Experimental Toxicology

Volumn 29, Issue 12, 2010, Pages 1034-1037

  Calabrese, Edward J ^a   Mattson, Mark P ^b   Calabrese, Vittorio ^c  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

adaptive response; biphasic; dose response; hormesis; hormetic; resveratrol; U shaped

Indexed keywords

INDOMETACIN; RESVERATROL;

BONE CELL; CARCINOGENESIS; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CLINICAL PROTOCOL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG RESPONSE; ENDOTHELIUM CELL; HEART MUSCLE CELL; HORMESIS; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; LUNG ALVEOLUS CELL; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; REPRODUCIBILITY; STOMACH ULCER;

ANIMALS; BIOMEDICAL RESEARCH; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; STILBENES;

EID: 78649936101     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110383641     Document Type: Note

References (20)

1. Espin JC, Garcia-Conesa MT, and Tomas-Barberan FA Nutraceuticals: facts and fiction. Phytochemistry 2007 ; 68: 2986-3008.
2. Calabrese EJ, Mattson MP, and Calabrese V. Resveratrol commonly displays hormesis: occurrence and biomedical significance. Hum Exper Toxicol 2010 ; 29: 980-1015.
3. Seward ZM (30 November 2006). Quest for youth drives craze for 'wine' pills. The Wall Street Journal, http://www.post-gazette.com/pg/06334/742471-114. stm
4. Das DK Commentary on 'Resveratrol commonly displays hormesis: Occurrence and biomedical significance' by Calabrese et al. Hum Exper Toxicol 2010 ; 29: 1016-1017.
5. De La Lastra CA Commentary on 'Resveratrol commonly displays hormesis: Occurrence and biomedical significance' by Calabrese et al. Hum Exper Toxicol 2010 ; 29: 1021-1023.
6. Hayes DP Commentary on 'Resveratrol commonly displays hormesis: Occurrence and biomedical significance' by Calabrese et al. Hum Exper Toxicol 2010 ; 29 ; 1018-1020.
7. Lindsay DG Commentary on 'Resveratrol commonly displays hormesis: Occurrence and biomedical significance' by Calabrese et al. Hum Exper Toxicol 2010 ; 29: 1024-1025.
8. Marques FZ, Morris BJ Commentary on 'Resveratrol and Hormesis: Resveratrol - a hormetic marvel in waiting? Hum Exper Toxicol 2010 ; 29: 1026-1028.
9. Tedesco I., Russo M., and Russo GL Commentary on "Resveratrol commonly displays hormesis: occurrence and biomedical significance". Hum Exper Toxicol 2010 ; 29: 1029-1031.
10. Young JF, Bhattacharya S. Commentary on "Resveratrol commonly displays hormesis: occurrence and biomedical significance". Hum Exper Toxicol 2010 ; 29: 1032-1033.
11. Mukherjee S., Dudley JI, and Das DK Dose-dependency of resveratrol in providing health benefits. Dose Response 2010 (in press).
12. Calabrese EJ Historical blunders: how toxicology got the dose-response relationship half right. Cell Mol Biol 2005 ; 51: 643-654.
13. Calabrese EJ Getting the dose response wrong. Why hormesis became marginalized and the threshold model accepted. Arch Toxicol 2009 a; 83: 227-247.
14. Calabrese EJ The road to linearity: why linearity at low doses became the basis for carcinogen risk assessment. Arch Toxicol 2009 b; 83: 203-225.
15. Calabrese EJ, Baldwin LA The frequency of U-shaped dose-responses in the toxicological literature. Tox Sci 2001 ; 62: 330-338.
16. Calabrese EJ, Baldwin LA The hormetic dose response model is more common than the threshold model in toxicology. Tox Sci 2003 a; 71: 246-250.
17. Calabrese EJ, Baldwin LA Toxicology rethinks its central belief-hormesis demands a reappraisal of the way risks are assessed. Nature 2003 b; 421: 691-692.
18. Calabrese EJ, Blain R. The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview. Toxicol Appl Pharmacol 2005 ; 202: 289-301.
19. Calabrese EJ, Staudenmayer JW, Stanek EJ, and Hoffmann GR Hormesis outperforms threshold model in NCI anti-tumor drug screening data. Toxicol Sci 2006 ; 94: 368-378.
20. Calabrese EJ, Stanek III EJ, Nascarella MA, and Hoffmann GR Hormesis predicts low-dose responses better than threshold models. Int J Toxicol 2008 ; 27: 369-378.